Ignite Creation Date:
2025-12-24 @ 2:46 PM
Ignite Modification Date:
2025-12-26 @ 4:44 PM
Study NCT ID:
NCT01590459
Status:
COMPLETED
Last Update Posted:
2015-11-20
First Post:
2012-04-27
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
24-week Study With Open Label Extension of VX-509, an Oral JAK3 Inhibitor, in Subjects Taking Methotrexate
Sponsor:
Vertex Pharmaceuticals Incorporated
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-04
Start Date Type:
None
Primary Completion Date:
2014-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-07
Completion Date Type:
ACTUAL
First Submit Date:
2012-04-27
First Submit QC Date:
None
Study First Post Date:
2012-05-03
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2015-11-20
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2015-10-23
Last Update Post Date:
2015-11-20
Last Update Post Date Type:
ESTIMATED